UPDATE 1-Henry Schein Q1 beats Wall Street
* Q1 adj EPS $0.75 vs. est $0.69
* Q1 revenue rose 19 pct to $1.76 bln
* Raises lower end of FY10 earnings outlook
* Sees Q2 EPS growth in mid-single digits
May 4 (Reuters) - Henry Schein Inc's (HSIC.O) adjusted quarterly profit topped estimates, helped by international business growth and a surge in North American veterinary sales, and the medical products supplier raised the lower end of its full-year profit outlook.
For the first quarter, net income from continuing operations rose to $60.9 million, or 66 cents a share, from $54.9 million, or 61 cents a share, in the year-ago period.
Excluding restructuring costs, the company posted a profit of 75 cents a share in the latest quarter.
Analysts on average expected a profit of 69 cents a share for the quarter, according to Thomson Reuters I/B/E/S.
Revenue rose 19 percent to $1.76 billion, beating analysts' estimates of $1.69 billion.
International sales were up 16 percent at $609.5 million.
"International growth reflects strong performance in the dental and veterinary businesses, as well as particular strength in France, Australia, Germany, Spain and Switzerland," Chief Executive Stanley Bergman said in a statement.
The company now expects 2010 earnings of $3.44 to $3.56 a share, excluding items, up from its earlier view of $3.40 to $3.56 a share.
Shares of the company closed at $61.10 Monday on Nasdaq. (Reporting by Shailesh Kuber in Bangalore; Editing by Unnikrishnan Nair)
- Deadly gun attack in eastern Ukraine shakes fragile Geneva accord |
- Japan expands army footprint for first time in 40 years, risks angering China
- Pfizer considers $100 billion bid for AstraZeneca: report
- Prosecutors extend Korea ferry captain's detention as death toll mounts |
- Rubin 'Hurricane' Carter, U.S. boxer famous in folk song, dies at 76